iodo-parathyroid hormone in the rat, uptake of the hormone was greatest in the liver and kidneys. Uptake was rapid, reaching a maximal concentration by 4 and 8 min, respectively. Extracts, prepared from both these organs at intervals soon after the injection of intact hormone, showed three main radioactive peaks when samples were subjected to gel filtration under proteindenaturing conditions. The first peak coeluted with intact hormone.The second eluted at a position corresponding to the carboxy-terminal fragments previously described in plasma, and the last eluted at the salt volume of the column. Microsequence analysis of the radioiodinated fragments, a method that has proved valuable for chemically defining the circulating fragments resulting from metabolism of injected hormone, showed that extracts of liver and kidney, prepared at 4 and 8 min after injection of the intact hormone, contained different fragments. The radioiodinated fragments in liver extracts were identical to those previously reported in the plasma of rats and dogs, fragments resulting principally from proteolysis between positions 33 and 34, and 36 and 37 of the intact hormone. Although the same fragments were also present in the kidneys, they constituted less than 15% of the amount present in the liver. More than 50% of the
labeled renal fragments consisted of a peptide whose amino-terminal amino acid was position 39 of the intact hormone, a fragment not present in plasma. The rate of appearance of radioiodinated fragments that were chemically identical to those in plasma was more rapid in the liver than in plasma. Correlation of these chemical analyses with studies of the localization of 125I by autoradiography showed that at the times when the intact hormone and the carboxy-terminal fragments comprised nearly all of the 1251-labeled moieties in the tissues, the proximal convoluted tubules of the kidney and sinusoidal lining cells of the liver, which probably are Kupffer cells, contained the highest concentration of 1251. Preferential localization of immunoreactive parathyroid hormone to these tissue sites also was shown by immunoperoxidase staining in studies with unlabeled hormone. Our results suggest that, unless multiple renal mechanisms are present for release of hormonal fragments, one of which releases the circulating fragments preferentially, the liver, rather than the kidney, is principally responsible for generating the carboxy-terminal fragments in plasma after injection of intact hormone, and the Kupffer cells may contain the enzymes that hydrolyze parathyroid hormone.
INTRODUCTION
Studies in anephric and uremic man (1-3) and animals (4, 5) and in partly hepatectomized rats (4) have shown that the kidneys and the liver are principally responsible for the metabolism and(or) clearance of parathyroid hormone (PTH)l or its fragments from the circulation. The important role of these two organs in PTH metabolism has been confirmed by measurements of arteriovenous differences in immunoreactive PTH across various organ beds of intact animals (6, 7) and by studies with isolated, perfused livers (8) and kidneys (9, 10) . The understanding of PTH metabolism has been complicated, however, by the finding that the functions of these two organs differ. Isolated, perfused livers and kidneys both release hormonal fragments of PTH into the perfusate (8, 9) . Both organs remove intact hormone from the plasma in vivo (11) , but only the kidney clears circulating fragments (11) . Studies in our laboratory have shown that negligible concentrations of circulating fragments appear after injection of bovine [1251] iodo-PTH to totally hepatectomized rats, indicating that the liver probably is the dominant contributor to circulating plasma fragments.2 Despite considerable attention, however, the biologic significance of hormonal metabolism remains uncertain. Microsequence analysis of the radioiodinated fragments in the plasma of rats (12) and dogs (13) after injection of bovine [1251] iodo-PTH, with the automated Edman reaction, demonstrated that identical peptide bonds of PTH are hydrolyzed in both species, principally those between positions 33 and 34, and 36 and 37 of the intact sequence. The specificity of this enzymic attack, coupled with evidence for differences in hepatic and renal handling of intact hormone and its fragments, suggests that hormonal metabolism may be an important physiologic reaction, controlling the availability of biologically active hormone in the circulation.
The present studies further examine the role of various organs in the uptake and metabolism of PTH and its fragments. Specific emphasis is placed on chemically identifying the labeled fragments of the hormone extracted from liver and kidney tissue and correlating these data with localization of the hormone and its fragments in these organs by autoradiography and immunoperoxidase staining.
METHODS
Preparation of radioiodinated peptides. Intact bovine PTH was purified by gel filtration and ion-exchange chromatography as previously described (14) . Bovine PTH fragment 1-34 was synthesized by solid-phase methods and purified as previously described (15) . Bovine serum albumin (Fraction V) was purchased from Armour Pharmaceutical Co., Kankakee, Ill.
Iodinations were performed with Na125I or Na131I (New England Nuclear, Boston, Mass.) by modifications (16) of the method of Hunter and Greenwood (17) . After iodination, hormonal preparations were initially purified by adsorption to QUSO-G-32 (Philadelphia Quartz Co., Valley Forge, Pa.), and then both hormonal preparations and the bovine serum albumin were gel-filtered as previously described (12) . barbital buffer, 10% plasma vol/vol, pH 8.6, some that also contained 13I-labeled bovine serum albumin (1.25 x 106 cpm), were quick-frozen in acetone-Dry Ice (Airco Industrial Gases, Div. of Airco Inc., Murray Hill, N. J.). Aliquots were stored for no more than 10 d at -70°C, and each aliquot was thawed only once.
Protocol for animal studies. Studies with bovine [1251] iodo-PTH were conducted in 48 white male rats (Charles River Breeding Laboratories, Wilmington, Mass.) that weighed 266±29 g and were anesthetized by i.p. injection of pentobarbital sodium (6 mg/100 g).
Tissue and organ uptakes of the radiolabeled preparations were studied after animals received rapid injection (20-30 s) , into the external jugular vein, of 0.5 ml of a solution that contained radiolabeled intact hormone and bovine serum albumin. Five rats were sacrificed by exsanguination through the abdominal aorta at the following intervals after injection of the hormone: 2, 4, 6, 8, 12, 24, 48, and 96 min. Blood, collected in heparinized syringes, was transferred to tubes and centrifuged at 3,000 g for 20 min at 4°C. Heart, spleen, liver, lungs, kidneys, a femur, and a sample of muscle were dissected, blotted, and weighed. A representative sample of each organ was also weighed. The total weights of bone and muscle were estimated to be 10.9 and 45.4%, respectively, ofthe total animal weight (18) . Urine was collected by bladder puncture from three animals 96 min after injection of the labeled hormone. After removal of aliquots for counting of the radioactivity, urine samples were immediately frozen in hexane-Dry Ice and then stored at -70°C. Triplicate 100-I,l plasma samples, duplicate 50-,ul samples of urines, and the portions of tissues and organs previously weighed were counted in a dual-channel well spectrometer (Packard Instrument Co., Inc., Downers Grove, Ill.). 125I and the ratio of 131I to 125I in all plasma and urine samples were calculated after correcting the 1251 counts for 1311.
The plasma volume of each rat was determined by the following equation: plasma volume (milliliters) = injected dose of '31I-labeled bovine serum albumin ( Details of the protocol were the same as above except that the liver and kidneys were immediately frozen in hexane-Dry Ice and then stored at -70°C. The amount of 1251 in these organs did not differ from that found in studies that quantitated the uptake of the tracer by these organs.
Additional studies were performed in 10 anesthetized, white male rats that weighed 270+10 g. 4 min after injection of ,ug of intact, unlabeled bovine PTH, the animals were sacrificed, and the kidneys and livers were removed and prepared for microscopical localization of PTH by the indirect peroxidase-labeled-antibody method of Mazurkiewicz and Nakane (19) .
Proceduresfor organ extraction. ). The liquid phase, between the lipid at the surface and the pellet, was recovered and gel-filtered. Less than 10% of the radioactivity, including the radioactivity in the centrifuged pellet, was lost during the extraction procedure.
For sequence analysis of samples, gel filtration of large amounts of tissue extract necessitated reducing the amount of tissue proteins in the samples. Most of the high molecular weight material was precipitated. Initially, 3 vol of ice-cold 0.2 N acetic acid and a saturated solution of ammonium acetate were added (1 ml/20 ml). After two centrifugations for 30 min at 40,000 g at 4°C, the supernates were recovered. The pellets were counted for radioactivity and discarded. The supernates were diluted with 5 vol of 0.2 N acetic acid and lyophilized twice to remove volatile salts. After reconstitution with water to restore the solution to 6 M with respect to guanidine, the solution was gel-filtered. Reducing the protein concentration permitted gel filtration of three to four times more of the sample. Total recovery of radioactivity for these samples ranged from 65 to 80%. Assessment of the bovine [131I]_ iodo-PTH by gel filtration assured that no degradation of the tracer had occurred.
Gelfiltration. Urine, made 6 M with respect to guanidine by addition of the salt, and duplicate tissue extracts from pools obtained at each of the times sampled were chromatographed on columns of Bio-Gel A 0.5 m (100-200 mesh, Bio-Rad Laboratories, Richmond, Calif.) equilibrated in and eluted with 6 M guanidine-HCl: 0.1 M ammonium acetate: 1% vol/vol plasma, pH 6.4. In most experiments, 200-,I samples were applied to columns (1.2 x 95 cm, fraction size = 2 ml), and 6 ml of samples for sequence analysis were filtered on columns (2.5 x 95 cm, fraction size = 2 ml). The 131I and 1251 in each fraction were counted, and the 1251 radioactivity was corrected both for 131j and for radioactive decay.
For sequence analysis, fractions in the region of the chromatogram that corresponded to the large carboxy (COOH)-terminal fragments seen in plasma samples (Rf = Ve -VONV8 -V0, where Ve = elution volume of the sample, V, = elution volume of salt, and V0 = void volume ofthe column) (Rf = 0.42 -0.58) (12) were pooled and gel-filtered on columns (5 x 50 cm) of Bio-Gel P-2 (100-200 mesh), equilibrated, and eluted with 1 N acetic acid at 4°C to remove the guanidine salt. All radioactivity eluted in the void volume. Recoveries ranged from 84 to 92%. The radioactive fractions were then pooled, lyophilized, frozen, and stored at -700C.
Radioactivity in each peak of the chromatograms was quantitated by planimetry, and the results were expressed in terms of the total organ uptake of radioactivity.
Edman degradations. Lyophilized samples were dissolved in heptafluorobutyric acid. Degradations were performed in the Beckman model 890 (Beckman Instruments, Inc., Spinco Div., Palo Alto, Calif.) with a single-coupling, double-cleavage program (20) . All procedures used for converting the anilinothiazolinone derivatives, for extracting the phenylthiohydantoin derivatives, and for identifying the radioiodinated derivatives were identical to those previously reported (12, 13) . All samples were degraded for at least 25 cycles, and several for more than 30 (22) . Tissues in Zamboni's fixative were then dehydrated with graded ethanol solutions and dioxane before they were embedded in paraffin. Sections of 4-6 ,um were mounted on slides and coated with liquid NTB-2 nuclear-tract emulsion (Eastman Kodak Co., Rochester, N. Y.). After a 1-d exposure, the autoradiographs were developed in Dektol (Eastman Kodak Co.) for 2 min at 28°C. Tissues in Karnovsky's fixative were embedded in epoxy resin after the method of Luft (23) . Sections of 1 ,um were mounted on slides and coated with liquid NTB-2 nuclear-tract emulsion diluted 1:8 with distilled water. After exposure for 1, 2, and 3 wk, the autoradiographs were developed with Dektol for 5 min at 28°C.
For immunoperoxidase localization of immunoreactive PTH, tissue fixed in Zamboni's solution was embedded in polyethylene glycol. Sections of4 ,um were treated with rabbit anti-bovine-PTH antisera (R-12) at a dilution of 1:10 for 24 h. R-12 is a multivalent antiserum that recognizes determinants in both the amino (NH2)-and COOH-terminal portions of the PTH sequence (24) . After the tissue was treated for 24 h with peroxidase-labeled goat anti-rabbit IgG (N. L. Cappel Laboratories Inc., Cochranville, Pa.), sections were stained according to the method of Karnovsky (22) . Tissue sections exposed to normal rabbit serum for 24 h, rather than to rabbit antibovine PTH antiserum, served as controls.
RESULTS
Distribution of 125I* Fig. 1 shows the disappearance of 1251 from the plasma space and the uptake and subsequent disappearance of radioactivity from various or- (Fig. 2) , and the quantity of each 125I-containing moiety, as determined by its elution position upon gel filtration, was calculated (Table   I ). The elution position of the principal radioactive peak (Rf = 0.37) in both the liver and the kidneys at 4 and 8 min after injection of the bovine [1251]iodo-PTH was coincident with the bovine [131 ] iodo-PTH and pre- I Total = percent of the injected dose of 125I contained in the organ. § The amount of radioactivity in each peak (Fig. 2) In addition, by 24 min the total amount of these fragments in both organs had decreased to 10.2% of the injected dose. Radioactivity eluting at the position of 1311 in the liver and kidneys increased from 3.6 and 0.6% at 4 min to a maximum at 24 min of 8.4 and 7.8%. At the later times studied, the predominant form of radioactivity eluted at the salt volume in both liver and kidneys. Over 99% of the 125I in the urine eluted at the salt volume; neither intact hormone nor the labeled COOH-terminal fragments were detected. Sequence analysis of the radiolabeled fragments. Automated Edman degradations were performed on extracts of both liver and kidney prepared 4 and 8 min after injection ofthe radioiodinated hormone. Gel chromatograms that resulted from gel filtration of 6-ml samples of these tissue extracts on columns (2.5 x 95 cm) were identical to those shown (Fig. 2) when differences in the amount ofradioactivity and size offractions were considered. Fractions between Rf of0.42 and 0.58 were subjected to sequence analysis (Fig. 3) 4A ) and to the lumenal surface of proximal convoluted tubules (Fig. 4B) . Strikingly fewer grains were seen over other tubular segments, the interstitium, and the tubular and glomerular capillaries. Only some of the proximal tubules appeared to contain 1251. By 8 min, the label continued to be predominantly localized to the lumen and the apical regions of the proximal tubular cells, although the distribution ofthe label appeared to be slightly more diffuse than it was at 4 min. By 24 min, labeling persisted in the proximal tubular lumens, and was less intense and distributed even more diffusely in proximal tubule cells. Some grains were also seen over the interstitium and tubular capillaries (figures not shown).
In the liver, the early localization (4 min) of 1251 was confined largely to sinusoidal lining cells, presumably Kupffer cells (Fig. 5) . Grains over hepatic cells were no greater than background. By 8 min, hepatic cells contained more grains, although still less than Kupffer cells, and, by 24 min, the grains were distributed in a uniform fashion over both hepatic and Kupffer cells (figure not shown).
With indirect immunoperoxidase staining, the reaction product was confined predominantly to the lumens and apical portions of the proximal convoluted tubules at 4 min after injection of the hormone (Fig. 6) . Stain ing of less intensity was also seen over the interstitium and glomerular capillaries. At 4 min, the reaction product localized in sinusoidal lining cells of the liver, presumably Kupffer cells, whereas hepatocytes appeared to be free of staining (Fig. 7) . Control slides of both kidney and hepatic tissue were free of the reaction product.
DISCUSSION
The results of these studies extend previous observations (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (25) (26) (27) (28) indicating that the liver and kidneys play critical roles in the metabolism and(or) clearance of PTH.
Uptake of bovine ['25I]iodo-PTH occurs rapidly in both the liver and kidneys after intravenous administration of the hormone. As shown in Table I , the amount of intact hormone taken up by the liver and kidneys was as high or higher by 4 min, the earliest sample analyzed, than it was at any later time. When expressed in terms of wet weight of the total organs, the amount in the liver was greater by a factor of 1.5. The amount of intact hormone in the liver decreased throughout the remainder of the experiment, whereas, in the kidney, the amount appeared to remain constant until 8 min after injection and decreased thereafter.
1251-labeled COOH-terminal fragments were present in the liver and kidney at the earliest time examined, 4 min after injection. The amount of this material in these organs was somewhat greater than previously reported by Neuman et al. (28) . However, the differences may be because of the time at which samples were obtained. Our results and those of Neuman et al. (28) agree that at times soon after injection of the hormone, there is more of the large COOH-terminal fragment in the liver than in the kidney and, at later times, the amount of this material in the kidney exceeds that in the liver. (12) . Therefore, because no significant renal contribution to the circulating fragment pool appears likely (vide supra), our data are most consistent with the hypothesis that circulating fragments result, principally at least, from metabolic processes occurring in the liver. It is important to note, however, that these studies are concerned only with the peripheral metabolism of PTH. They do not directly further our understanding of the relative contributions of peripheral metabolism of intact secreted hormone and secretion of hormonal fragments by the parathyroid glands to the heterogeneity ofendogenous PTH in plasma, an issue that remains unsettled (16, (29) (30) (31) (32) .
Autoradiographic studies show that at the times when over 80% of the radioactivity in the kidney is either in intact hormone or in the large COOH-terminal fragments, 125I (27) may well be because of times at which their samples were taken, which were at least 1 h after continuous infusion of PTH. Autoradiography localized 1251 to the Kupffer cells of the liver at early times, when over 80% of the radioactivity in the liver is in either intact hormone or the COOH-terminal fragments. This was confirmed with the immunoperoxidase technique. Although these findings have not been reported for PTH, localization of insulin (33) (34) (35) , glucagon (36) , growth hormone (37) (38) (39) , luteinizing hormone, and follicle-stimulating hormone (40, 41) , human chorionic gonadotropin (42) , and prolactin (43) (13) , and our current data-showing that localization of 125I-labeled and unlabeled preparations are identical, indicate that the metabolism ofthe radioiodinated PTH used in these studies accurately reflects the metabolism of unlabeled hormone.
Several studies have indicated that the liver is of primary importance in the proteolysis of PTH to fragments (3, 8, 11, 28 
